Prognostic value of serum high mobility group 1 in newborns with neonatal encephalopathy
Bano, S., Chaudhary, V. & Garga, UC Neonatal hypoxic-ischemic encephalopathy: A radiological study. J. Pediatrics. Neuroscience. 121 (2017).
Greco, P. et al. Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a look into the future. Acta Neurol. Belg. 120277–288 (2020).
Liu, W. et al. Prognostic value of clinical tests in neonates with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia: a systematic review and meta-analysis. Front. Neurol. 11133 (2020).
Aliyu, I., Lawal, TO & Onankpa, B. Hypoxic-ischemic encephalopathy and the Apgar scoring system: the experience in a resource-limited setting. J. Clinical Sciences. 1518–21 (2018).
Shankaran, S. Neonatal encephalopathy: treatment with hypothermia. NeoReviews 11e85–e92 (2010).
Volpe JJ Neurology of the Newborn, E-Book. (2008).
Cizmeci MN, Martinez-Biarge M, Cowan FM The predictive role of brain magnetic resonance imaging in neonates with hypoxic-ischemic encephalopathy. Pediatric Res. 95601–602 (2023).
Apgar, V. A proposal for a new method of evaluating newborns. Originally published July 1953, Volume 32, pages 250-259. Anesthesia. Analg. 1201056–1059 (2015).
Barkovich, AJ et al. Predicting neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. AJNR Am. J. Neuroradiol. 19143–149 (1998).
Rutherford, M. et al. Assessment of brain tissue injury following moderate hypothermia in neonates with hypoxic-ischemic encephalopathy: a nested substudy of a randomized controlled trial. Lancet Neurol. 939–45 (2010).
Sie, LT et al. Early MR features of hypoxic-ischemic brain injury in neonates with periventricular sonographic densities. Am. J. Neuroradiol. 21852–861 (2000).
Hellström-Westas, L., Rosen, I. & Svenningsen, NW. Predictive value of early continuous amplitude-integrated EEG recordings for outcome after severe birth asphyxia in full-term infants. Arch. Dis. Child.-Fetal Newborn Education. 72F34–F38 (1995).
al Naqeeb, N., Edwards, AD, Cowan, FM & Azzopardi, D. Assessment of neonatal encephalopathy by amplitude-integrated electroencephalography. Pediatrics 1031263–1271 (1999).
Edwards, AD et al. Neurologic outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic-ischemic encephalopathy: synthesis and meta-analysis of study data. BMJ 340c363 (2010).
Lotze, MT & Tracey, KJ High-Mobility Group Box 1 protein (HMGB1): nuclear weapon in the arsenal of the immune system. Nat. Rev. Immunol. 5331–342 (2005).
Andersson, U. & Tracey, KJ HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29139–162 (2011).
Hatayama, K. et al. High-mobility group box-1 and interalpha inhibitor proteins: in vitro binding and colocalization in the cerebral cortex after hypoxic-ischemic injury. FRANK F. 35e21399 (2021).
Chen, X. et al. Translocation and release of high-mobility group box-1 after hypoxic ischemic brain injury in neonatal rats. Exp. Neurol. 3111–14 (2019).
Zhang, J. et al. HMGB1 translocation after ischemia in the fetal sheep brain. J. Neuropathol. Exp. Neurol. 75527–538 (2016).
Harris, HE, Andersson, U. & Pisetsky, DS HMGB1: A multifunctional alarmin causing autoimmune and inflammatory diseases. Nat. Rev. Rheumatol. 8th195–202 (2012).
Saito Reis, CA, Padron, JG, Norman Ing, ND & Kendal‐Wright, CE High mobility group 1 is a trigger of inflammation throughout pregnancy. Am. J. Reprod. Immunol. 85e13328 (2021).
Nakamura, T., Yamada, S. & Yoshioka, T. Hypothermic brain therapy dramatically reduces elevated blood concentrations of High Mobility Group Box 1 in neonates with hypoxic-ischemic encephalopathy. Dis.-Marker 35327–330 (2013).
Paudel, YN, Angelopoulou, E., Piperi, C., Othman, I. & Shaikh, MF HMGB1-mediated neuroinflammatory responses in brain injury: possible mechanisms and therapeutic opportunities. Int. J. Mol. Sci. 214609 (2020).